Avenue Therapeutics, Inc. (ATXI)
OID · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include ATX-04, a small molecule therapy for the treatment of Pompe disease; and intravenous tramadol, a schedule IV opioid to treat post-operative acute pain. The company was incorporated in 2015 and is headquartered in Bay Harbor Islands, Florida.
Peers in Healthcare
Avenue Therapeutics, Inc. has no peer companies in this window.
Recent press releases
Avenue Therapeutics, Inc. has not issued a press release in this window.
SEC filings
All filings →Avenue Therapeutics, Inc. has not filed an SEC document in this window.
Insider trades
All insider trades →Avenue Therapeutics, Inc. has no reported insider trades in the last 90 days.